PM

Pagadalu Muni Sanjeevi Hemanth Kumar

Active Director Director DIN 10135122
DIN 10135122 First appointment Apr 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Pagadalu Muni Sanjeevi Hemanth Kumar

Data last updated:

Pagadalu Muni Sanjeevi Hemanth Kumar is a Director at Anexhome Healthcare Private Limited (since 2023).

DIN 10135122
Primary Designation Director
First Appointment 26 Apr 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Anexhome Healthcare Private Limited U86909KA2023PTC172840
Director26 Apr 20232023Active

Board colleagues of Pagadalu Muni Sanjeevi Hemanth Kumar

NameDINCompanyDesignation
Priyanka Nayak10135123Anexhome Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Anexhome Healthcare Private Limited
Premium access

Shareholding and investment profile for Pagadalu Muni Sanjeevi Hemanth Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pagadalu Muni Sanjeevi Hemanth Kumar

Pagadalu Muni Sanjeevi Hemanth Kumar currently holds 1 directorship: Anexhome Healthcare Private Limited (Director, since 26 Apr 2023).

Pagadalu Muni Sanjeevi Hemanth Kumar was first appointed on 26 Apr 2023 as Director at Anexhome Healthcare Private Limited.

The current boards of Pagadalu Muni Sanjeevi Hemanth Kumar's companies include Priyanka Nayak (Anexhome Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available